Company Overview of Virobay Inc.
Key Executives for Virobay Inc.
|Robert F. G. Booth Ph.D.||45 Relationships||Co-Founder, Chairman, Chief Executive Officer, President and Secretary||63|
|Heather Preston M.D.||36 Relationships||Co-Founder and Director||51|
|Kyle C. Elrod B.A.||No Relationships||Senior Vice President of Project Management and Operations||50|
|Elizabeth G. Shigezumi||No Relationships||Head of Clinical Operations and Clinical Trial Manager of Clinical Operations||58|
Virobay Inc. Board Members*
|Name||Board Relationships||Primary Company||Age|
|Robert F. G. Booth Ph.D.||45 Relationships||Virobay Inc.||63|
|Heather Preston M.D.||36 Relationships||Virobay Inc.||51|
|Thomas John Dietz Ph.D.||82 Relationships||Eiger BioPharmaceuticals, Inc.||53|
|Daniel S. Janney MBA||78 Relationships||Alta Partners LP||52|
|Jeffrey W. Bird M.D., Ph.D.||91 Relationships||Verinata Health, Inc.||57|
Virobay Inc. Executive Committees*
|Committee Name||Chairperson||Board Relationships||Members|
|Audit Committee Ph.D.||Thomas John Dietz||82 Relationships||3 Executives|
|Compensation Committee Ph.D.||Thomas John Dietz||82 Relationships||3 Executives|
|Nominating Committee M.D.||Heather Preston||36 Relationships||3 Executives|
|Corporate Governance Committee M.D.||Heather Preston||36 Relationships||3 Executives|
The information and data displayed in this profile are created and managed by S&P Global Market Intelligence, a division of S&P Global. Bloomberg.com does not create or control the content. For inquiries, please contact S&P Global Market Intelligence directly by clicking here.
CEO COMPENSATION IN THIS INDUSTRY
|Total Short Term Compensation|
|Total Value of Options||$355.4K|
INDUSTRY EXECUTIVE CHANGES
Sponsored Financial Commentaries
Only a company representative may request an update for the company profile. Documentation will be required.